Sign inJoin waitlistJoin the waitlist

Sarah Kattakuzhy

Medical Director for the Kahlert Institute for Addiction Medicine · Univ of Maryland Sch of Med

Credentials: · · · ·

History

Univ of Maryland Sch of Med
Present
Research Initiative on Infectious Disease and Substance Use Disorder · Univ of Maryland Sch of Med
Present
Univ of Maryland Sch of Med
Present

Frederick National Laboratory for Cancer Research
2012–2014
Internal Medicine
George Washington University School of Medicine
2010–2012
Eastern Virginia Medical School
2005–2009
2000-2004 BS, Biology and BS, Psychology, Virginia Commonwealth University
2004

Research

Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial
Annals of Internal Medicine · 2017 · First of 18 authors · 195 citations
Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs
Clinical Infectious Diseases · 2020 · Last of 20 authors · 106 citations
Opioids and Infectious Diseases: A Converging Public Health Crisis
The Journal of Infectious Diseases · 2019 · 79 citations

ER
Elana Rosenthal
34 papers · 2 as a fellow
Shyam Kottilil
29 papers
Henry Masur
22 papers
EW
Eleanor Wilson
10 papers
LT
Lydia Tang
9 papers
Alaina Steck
8 papers
Jillian Catalanotti
8 papers
Joseph Carpenter
8 papers
Christopher Brokus
7 papers · 2 as a resident
Poonam Mathur
6 papers
Edward Traver
5 papers · 1 as a fellow
Ellen Eaton
5 papers

Grants

ARTEMIS: Advancing Addiction Research and Treatment Through Engagement with Rural Marylanders Impacted by PolySubstance Use
National Institute on Drug Abuse · R24
Contact PI · $1.3M · University of Maryland Baltimore
2024–2029
Peer-Delivered, Behavioral Activation Intervention to Improve Polysubstance Use and Retention in Mobile Telemedicine OUD Treatment in an Underserved, Rural Area
National Institute on Drug Abuse · R01
PI · $4.2M · Univ of Maryland, College Park
2022–2027

Clinical trials

Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
Principal investigator · Recruiting
University of Maryland, College Park
2023–2027
Safety and Preliminary Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People With Opioid Use Disorder
Principal investigator · Withdrawn · Phase 2
University of Maryland, Baltimore
2021
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
Sub-investigator · Recruiting
Elana Rosenthal
2024–2027